UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
BioNTech
BNTX
$23.5B
| – | – |
-256,874
| Closed | -$27.3M |
|
2327
Boston Omaha
BOC
$436M
| – | – |
-51,098
| Closed | -$717K |
|
|
BPMC
2328
DELISTED
Blueprint Medicines
BPMC
| – | – |
-215,946
| Closed | -$27.7M |
|
2329
Popular Inc
BPOP
$11.1B
| – | – |
-66,721
| Closed | -$7.35M |
|
|
BRKL
2330
DELISTED
Brookline Bancorp
BRKL
| – | – |
-253,246
| Closed | -$2.67M |
|
|
BRY
2331
DELISTED
Berry Corp
BRY
| – | – |
-19,332
| Closed | -$53.5K |
|
2332
Banco Santander Chile
BSAC
$16.6B
| – | – |
-344,316
| Closed | -$8.68M |
|
2333
Baytex Energy
BTE
$2.92B
| – | – |
-461,486
| Closed | -$826K |
|
2334
B2Gold
BTG
$6.64B
| – | – |
-1,961,073
| Closed | -$7.08M |
|
2335
Bioventus
BVS
$1.19B
| – | – |
-144,435
| Closed | -$956K |
|
2336
Blackstone Mortgage Trust
BXMT
$2.38B
| – | – |
-652,417
| Closed | -$12.6M |
|
2337
CAE Inc. Common Shares
CAE
$8.74B
| – | – |
-414,350
| Closed | -$12.1M |
|
2338
Camtek
CAMT
$7.25B
| – | – |
-872,730
| Closed | -$73.8M |
|
2339
Capricor Therapeutics
CAPR
$237M
| – | – |
-92,176
| Closed | -$915K |
|
2340
Chubb
CB
$135B
| – | – |
-3,099,871
| Closed | -$898M |
|
|
CBL
2341
CBL Properties
CBL
$1.75B
| – | – |
-34,874
| Closed | -$885K |
|
2342
Cameco
CCJ
$42.4B
| – | – |
-760,211
| Closed | -$56.4M |
|
2343
CNB Financial Corp
CCNE
$1.03B
| – | – |
-18,246
| Closed | -$417K |
|
|
CGAU
2344
Centerra Gold
CGAU
$4.15B
| – | – |
-235,238
| Closed | -$1.7M |
|
|
CHCT
2345
Community Healthcare Trust
CHCT
$454M
| – | – |
-114,266
| Closed | -$1.9M |
|
|
CHX
2346
DELISTED
ChampionX
CHX
| – | – |
-669,484
| Closed | -$16.6M |
|
2347
Colliers International
CIGI
$5.19B
| – | – |
-44,053
| Closed | -$5.75M |
|
2348
Cellebrite
CLBT
$3.99B
| – | – |
-288,736
| Closed | -$4.62M |
|
|
CLLS
2349
Cellectis
CLLS
$285M
| – | – |
-3,178,620
| Closed | -$4.85M |
|
2350
Celestica
CLS
$36.5B
| – | – |
-105,764
| Closed | -$16.5M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.